Philips blamed the effects of the global recession and uncertainty surrounding US healthcare reform for its weak revenue growth in fiscal 2009. The company’s full-year healthcare sales grew by around 2% on a nominal basis to €7.84bn ($10.7bn), largely due to contributions ...
Please Login to read the full article.
